Literature for inhibitor I35.004: timp-4

(Topics flags: M Mutation, I Inhibitor, E Expression, L Localization, U Therapeutic. To select only the references relevant to a single topic, click the link above. See explanation.)

2024
1. Cavalcante,G.L., Bonifacio,L.P., Sanches-Lopes,J.M., Puga,F.G., de Carvalho,F.S., Bellissimo-Rodrigues,F. and Tanus-Santos,J.E.
   Matrix metalloproteinases are associated with severity of disease among COVID-19 patients: A possible pharmacological target
   Basic Clin Pharmacol Toxicol (2024) 134, 727-736. PubMed  Europe PubMed DOI  L
2. Dibdiakova,K., Majercikova,Z., Galanda,T., Richterova,R., Kolarovszki,B., Racay,P. and Hatok,J.
   Relationship between the Expression of Matrix Metalloproteinases and Their Tissue Inhibitors in Patients with Brain Tumors
   Int J Mol Sci (2024) 25 PubMed  Europe PubMed DOI  PMC  EPMC
2016
3. Guo,C., Tsigkou,A. and Lee,M.H.
   ADAMTS13 and 15 are not regulated by the full length and N-terminal domain forms of TIMP-1, -2, -3 and -4
   Biomed Rep (2016) 4, 73-78. PubMed  Europe PubMed DOI  PMC  EPMC  I
2014
4. Tsai,H.T., Hsieh,M.J., Chiou,H.L., Lee,H.L., Hsin,M.C., Liou,Y.S., Yang,C.C., Yang,S.F. and Kuo,W.H.
   TIMP-3 -1296 T>C and TIMP-4 -55 T>C gene polymorphisms play a role in the susceptibility of hepatocellular carcinoma among women
   Tumour Biol (2014) 35, 8999-9007. PubMed  Europe PubMed DOI  M
5. Zavadzkas,J.A., Stroud,R.E., Bouges,S., Mukherjee,R., Jones,J.R., Patel,R.K., McDermott,P.J. and Spinale,F.G.
   Targeted overexpression of tissue inhibitor of matrix metalloproteinase-4 modifies post-myocardial infarction remodeling in mice
   Circ Res (2014) 114, 1435-1445. PubMed  Europe PubMed DOI  U
2004
6. [YEAR:1-10-2004]Guo,Y.H., Gao,W., Li,Q., Li,P.F., Yao,P.Y. and Chen,K.
   Tissue inhibitor of metalloproteinases-4 suppresses vascular smooth muscle cell migration and induces cell apoptosis
   Life Sci (1-10-2004) 75, 2483-2493. PubMed  Europe PubMed DOI
7. Pilka,R., Domanski,H., Hansson,S., Eriksson,P. and Casslen,B.
   Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26
   Mol Hum Reprod (2004) 10, 641-650. PubMed  Europe PubMed DOI
2003
8. [YEAR:20-5-2003]Schulze,C.J., Wang,W., Suarez-Pinzon,W.L., Sawicka,J., Sawicki,G. and Schulz,R.
   Imbalance between tissue inhibitor of metalloproteinase-4 and matrix metalloproteinases during acute myocardial [correction of myoctardial] ischemia-reperfusion injury
   Circulation (20-5-2003) 107, 2487-2492. PubMed  Europe PubMed DOI
2002
9. [YEAR:17-12-2002]Troeberg,L., Tanaka,M., Wait,R., Shi,Y.E., Brew,K. and Nagase,H.
   E. coli expression of TIMP-4 and comparative kinetic studies with TIMP-1 and TIMP-2: insights into the interactions of TIMPs and matrix metalloproteinase 2 (gelatinase A)
   Biochemistry (17-12-2002) 41, 15025-15035. PubMed  Europe PubMed DOI
2001
10. [YEAR:1-5-2001]Bigg,H.F., Morrison,C.J., Butler,G.S., Bogoyevitch,M.A., Wang,Z.P., Soloway,P.D. and Overall,C.M.
    Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase
    Cancer Res (1-5-2001) 61, 3610-3618. PubMed  Europe PubMed
11. [YEAR:13-4-2001]Hashimoto,G., Aoki,T., Nakamura,H., Tanzawa,K. and Okada,Y.
    Inhibition of ADAMTS4 (aggrecanase-1) by tissue inhibitors of metalloproteinases (TIMP-1, 2, 3 and 4)
    FEBS Lett (13-4-2001) 494, 192-195. PubMed  Europe PubMed DOI
12. [YEAR:15-3-2001]Jiang,Y.F., Wang,M.S., Celiker,M.Y., Liu,Y.E., Sang,Q.X.A., Goldberg,I.D. and Shi,Y.E.
    Stimulation of mammary tumorigenesis by systemic tissue inhibitor of matrix metalloproteinase 4 gene delivery
    Cancer Res (15-3-2001) 61, 2365-2370. PubMed  Europe PubMed
13. [YEAR:2-11-2001]Stratmann,B., Farr,M. and Tschesche,H.
    MMP-TIMP interaction depends on residue 2 in TIMP-4
    FEBS Lett (2-11-2001) 507, 285-287. PubMed  Europe PubMed DOI
14. Tummalapalli,C.M., Heath,B.J. and Tyagi,S.C.
    Tissue inhibitor of metalloproteinase-4 instigates apoptosis in transformed cardiac fibroblasts
    J Cell Biochem (2001) 80, 512-521. PubMed  Europe PubMed DOI
2000
15. [YEAR:29-12-2000]Toth,M., Bernardo,M.M., Gervasi,D.C., Soloway,P.D., Wang,Z., Bigg,H.F., Overall,C.M., DeClerck,Y.A., Tschesche,H., Cher,M.L., Brown,S., Mobashery,S. and Fridman,R.
    Tissue inhibitor of metalloproteinase (TIMP)-2 acts synergistically with synthetic matrix metalloproteinase (MMP) inhibitors but not with TIMP-4 to enhance the (Membrane type 1)-MMP-dependent activation of pro-MMP-2
    J Biol Chem (29-12-2000) 275, 41415-41423. PubMed  Europe PubMed DOI
1997
16. Bigg,H.F., Shi,Y.E., Liu,Y.E., Steffensen,B. and Overall,C.M.
    Specific, high affinity binding of tissue inhibitor of metalloproteinases-4 (TIMP-4) to the COOH-terminal hemopexin-like domain of human gelatinase A. TIMP-4 binds progelatinase A and the COOH-terminal domain in a similar manner to TIMP-2
    J Biol Chem (1997) 272, 15496-15500. PubMed  Europe PubMed DOI
17. Gomez,D.E., Alonso,D.F., Yoshiji,H. and Thorgeirsson,U.P.
    Tissue inhibitors of metalloproteinases: structure, regulation and biological functions
    Eur J Cell Biol (1997) 74, 111-122. PubMed  Europe PubMed
18. Liu,Y.E., Wang,M., Greene,J., Su,J., Ullrich,S., Li,H., Sheng,S., Alexander,P., Sang,Q.A. and Shi,Y.E.
    Preparation and characterization of recombinant tissue inhibitor of metalloproteinase 4 (TIMP-4)
    J Biol Chem (1997) 272, 20479-20483. PubMed  Europe PubMed DOI  E
19. Wang,M., Liu,Y.E., Greene,J., Sheng,S., Fuchs,A., Rosen,E.M. and Shi,Y.E.
    Inhibition of tumor growth and metastasis of human breast cancer cells transfected with tissue inhibitor of metalloproteinase 4
    Oncogene (1997) 14, 2767-2774. PubMed  Europe PubMed DOI